CU Cancer Center Lung Cancer Treatment to be Commercialized by Syndax Pharmaceutical
May 9, 2013 · Comments Off on CU Cancer Center Lung Cancer Treatment to be Commercialized by Syndax Pharmaceutical
Licensing agreement allows development of a novel combination therapeutic for non-small-cell lung carcinoma, a type of lung cancer difficult to treat with conventional chemotherapy.
The current state of lung cancer treatment
December 11, 2012 · Comments Off on The current state of lung cancer treatment
A review in the December issue of the journal Archives of Pathology & Laboratory Medicine by Paul Bunn Jr, MD, University of Colorado Cancer Center investigator and past president of ASCO, IASLC and AACI describes the current state of lung cancer care.
Drug combination nearly doubles survival for subset of advanced non-small cell lung cancer patients
April 26, 2012 · Comments Off on Drug combination nearly doubles survival for subset of advanced non-small cell lung cancer patients
THREE KEY POINTS: Results of 30-center phase II clinical trial show that combination of erlotinib...
First and only drug for ALK-positive lung cancer approved today
August 26, 2011 · Comments Off on First and only drug for ALK-positive lung cancer approved today
Aurora, CO (8.26.2011) – In a major triumph for personalized medicine, today the FDA approved...
Study: Iloprost improves lung damage in nonsmokers
April 26, 2011 · Comments Off on Study: Iloprost improves lung damage in nonsmokers
Researchers at the University of Colorado Cancer Center have shown that use of an oral...
New combo lung cancer therapy improves survival over single-line treatment
December 14, 2010 · Comments Off on New combo lung cancer therapy improves survival over single-line treatment
University of Colorado-developed treatment effective in Phase 2 Trials in a biomarker-selected group of patients...
Setting the Gold Standard
March 15, 2009 · Comments Off on Setting the Gold Standard
When Dr. Marileila Varella-Garcia got an email in 2004, she opened the attached spreadsheet and...
Celebrating a 20-year collaboration with CSU’s Animal Cancer Center
December 1, 2008 · Comments Off on Celebrating a 20-year collaboration with CSU’s Animal Cancer Center
In June, the University of Colorado and Colorado State University celebrated 20-plus years of collaboration in cancer research. Colorado State is one of the three academic institutions that make up CU Cancer Center, alongside University of Colorado Denver and University of Colorado Boulder.
Bitter melon juice prevents pancreatic cancer in mouse models
December 1, 2008
Dietary supplements shown to increase cancer risk
December 1, 2008
AACR amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Have a wonderful weekend! http://t.co/GkkGFDflE9
CU researcher used human blood stem cells to grow “humanized” mouse immune system prior to tumor transplantation ow.ly/M22Pq
Today is the start to @CancerCon! We hope to see you at our booth!